Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of pentavalent meningococcal conjugate vaccine (NmCV-5)
PACTR201908558841221Phase 3Unknown
- Sponsor
- Serum Institute of India
- Start
- Aug 2019
- Countries
- 2
01
Overview
Phase 3 trial in meningococcal meningitis (2 arms), sponsored by Serum Institute of India. Primary endpoints: Seroresponse and Geometric mean titers. Status: unknown.
02
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on PACTR201908558841221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201908558841221.